Literature DB >> 19669669

Pro-inflammatory cytokines of rat vasculature in DOCA-salt treatment.

Behjat Seifi1, Mehri Kadkhodaee, Jie Xu, Manoocher Soleimani.   

Abstract

The purpose of this study was to ascertain the onset expression of pro-inflammatory cytokines in the aorta and kidney and establish their correlation with the increase in arterial blood pressure in rats subjected to DOCA-salt treatment. Male Sprague-Dawley rats underwent unilateral nephrectomy and received subcutaneous DOCA (20 mg/rat/week) as well as 1% NaCl and 0.2% KCl for drinking for 2 weeks. Blood pressure and expression of pro-inflammatory cytokines in aorta and kidney were studied weekly during the induction of hypertension. The treated rats exhibited a mild elevation of blood pressure at 1 week and a profound increase at 2 weeks. Quantitative RT-PCR demonstrated a 4.9-fold and a 3.6-fold enhancement in the expression of TNF-alpha and IL-6, respectively, in aorta as early as 1 week. The expression of IL-6 and TNF-alpha in the kidney remained almost unchanged at 1 week but mildly increased at 2 weeks DOCA-salt treatment. This study indicates a robust increase in the expression of IL-6 and TNF-alpha in aorta in DOCA-salt treated rats. This enhancement suggests that the activation of pro-inflammatory cytokines may contribute to onset of the elevation of blood pressure in DOCA-salt hypertension model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19669669     DOI: 10.1007/s11033-009-9676-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  15 in total

Review 1.  The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications.

Authors:  Juan F Navarro; Carmen Mora-Fernández
Journal:  Cytokine Growth Factor Rev       Date:  2006-11-20       Impact factor: 7.638

2.  Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension.

Authors:  Ahmed A Elmarakby; Jeffrey E Quigley; David M Pollock; John D Imig
Journal:  Hypertension       Date:  2006-01-16       Impact factor: 10.190

3.  Tranilast antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells.

Authors:  K Miyazawa; J Fukuyama; K Misawa; S Hamano; A Ujiie
Journal:  Atherosclerosis       Date:  1996-04-05       Impact factor: 5.162

4.  Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.

Authors:  J M Fernandez-Real; M Vayreda; C Richart; C Gutierrez; M Broch; J Vendrell; W Ricart
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

5.  Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats.

Authors:  Satoshi Kagitani; Hitoshi Ueno; Satoshi Hirade; Toru Takahashi; Masanobu Takata; Hiroshi Inoue
Journal:  J Hypertens       Date:  2004-05       Impact factor: 4.844

6.  Upregulation of interleukin-8/CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats.

Authors:  Hyo Young Kim; Young Jin Kang; In Hwan Song; Hyung Chul Choi; Hee Sun Kim
Journal:  Hypertens Res       Date:  2008-03       Impact factor: 3.872

7.  Reduced endothelial NO-cGMP-mediated vascular relaxation and hypertension in IL-6-infused pregnant rats.

Authors:  Julia M Orshal; Raouf A Khalil
Journal:  Hypertension       Date:  2004-01-05       Impact factor: 10.190

8.  Systemic hemodynamics in non-anesthetized L-NAME- and DOCA-salt-treated mice.

Authors:  Michael Obst; Volkmar Gross; Friedrich C Luft
Journal:  J Hypertens       Date:  2004-10       Impact factor: 4.844

9.  EFFECTS OF CHRONIC EXCESS SALT INGESTION. ROLE OF GENETIC FACTORS IN BOTH DOCA-SALT AND RENAL HYPERTENSION.

Authors:  L K DAHL; M HEINE; L TASSINARI
Journal:  J Exp Med       Date:  1963-10-01       Impact factor: 14.307

10.  Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo.

Authors:  Barbara Coles; Ceri A Fielding; Stefan Rose-John; Jürgen Scheller; Simon A Jones; Valerie B O'Donnell
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

View more
  5 in total

Review 1.  Potential mechanisms of hypothalamic renin-angiotensin system activation by leptin and DOCA-salt for the control of resting metabolism.

Authors:  Sarah A Sapouckey; Guorui Deng; Curt D Sigmund; Justin L Grobe
Journal:  Physiol Genomics       Date:  2017-10-06       Impact factor: 3.107

2.  Differential role of afferent and efferent renal nerves in the maintenance of early- and late-phase Dahl S hypertension.

Authors:  Jason D Foss; Gregory D Fink; John W Osborn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-12-09       Impact factor: 3.619

3.  Peroxisome Proliferator-Activated Receptor-α Activation Decreases Mean Arterial Pressure, Plasma Interleukin-6, and COX-2 While Increasing Renal CYP4A Expression in an Acute Model of DOCA-Salt Hypertension.

Authors:  Dexter L Lee; Justin L Wilson; Rong Duan; Tamaro Hudson; Ahmed El-Marakby
Journal:  PPAR Res       Date:  2011-12-07       Impact factor: 4.964

4.  Effect of aminoguanidine on cardiovascular responses and survival time during blood loss: A study in normotensive and deoxycorticosterone acetate-salt hypertensive rats.

Authors:  Babak Barmaki; Majid Khazaei
Journal:  Int J Appl Basic Med Res       Date:  2015 Jan-Apr

5.  Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension.

Authors:  Huijing Xia; Srinivas Sriramula; Kavaljit H Chhabra; Eric Lazartigues
Journal:  Circ Res       Date:  2013-09-06       Impact factor: 17.367

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.